TEFCA QHIN-to-QHIN FHIR Exchange to be Piloted in 2025 - ChatMedical.ai: Global Search, Local Care | The Future of Medical Consultation


ChatMedical.AI, an innovator in AI healthcare, is a key subsidiary of UL Cell Therapeutic, a leading medical research firm based in Singapore with significant operations in North America and Asia